Condition
    Preliminary
    Effectiveness 3/5

    Niacinamide for Skin Redness

    Topical niacinamide improves barrier function and can reduce redness, but the strong oral evidence is for skin cancer prevention, not rosacea.

    Overview

    Topical niacinamide improves barrier function and can reduce redness, but the strong oral evidence is for skin cancer prevention, not rosacea.

    Verdict

    Mixed evidence

    Mixed. Topical formulations have modest supportive data; oral niacinamide is not a rosacea treatment.

    How It Works

    Niacinamide increases ceramide and free fatty acid synthesis in the stratum corneum, improving barrier integrity and reducing transepidermal water loss, with anti-inflammatory effects on cytokine release.

    Dosing & Protocol

    Typical dose

    Recommended dose
    Topical 4-5% twice daily; oral 500mg twice daily
    Expected timeframe
    4-8 weeks topically

    Protocol

    form
    Topical niacinamide 2-5%
    duration
    8-12 weeks
    co factor
    Apply to damp skin, follow with a bland moisturiser, and use broad-spectrum SPF daily - UV is the main driver of facial redness. Avoid layering with strong acids or retinoids in the same application while assessing.
    titration
    Increase to twice daily after one week if there is no stinging; higher percentages raise irritation without clear benefit
    starting dose
    A 2-4% niacinamide serum or cream once daily to the affected area

    Evidence

    What the studies say

    Barrier impairment is central to rosacea: a compromised stratum corneum lets irritants through, producing the stinging and burning that make most skincare intolerable. Topical niacinamide at 4-5% improves barrier lipids and reduces transepidermal water loss in controlled studies, and small rosacea studies report improved tolerance and modest erythema reduction, though trials are short and often industry-sponsored. Oral niacinamide has strong evidence in a different setting entirely — the ONTRAC trial showed reduced keratinocyte cancers in high-risk patients — and this does not transfer to rosacea. Used topically, niacinamide is a sensible barrier-support ingredient that pairs well with sun protection; it is not a substitute for ivermectin or azelaic acid.

    Changes in ultraviolet B radiation-induced DNA damage and erythema after oral nicotinamide and polypodium leucotomos in healthy volunteers: an intraindividual controlled trial

    Score: 6/10
    2025
    rct
    n=47

    Faisal A

    NAM did not provide protection against erythema or DNA damage.

    View source

    Safety

    Caveats

    A minority flush with topical niacinamide, particularly at higher concentrations — patch test first. Oral niacinamide is not the same as niacin, which causes marked flushing and would be counterproductive.

    Less likely to help if

    People with predominantly papulopustular rosacea need prescription treatment; niacinamide addresses the barrier, not the inflammatory lesions.

    Medical Disclaimer

    The information provided on this website is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any supplement regimen.

    Individual results may vary. The statements on this website have not been evaluated by the Food and Drug Administration. Products and information are not intended to diagnose, treat, cure, or prevent any disease.